Preclinical efficacy of Dexmedetomidine on spinal cord injury provoked oxidative renal damage

References

• Beattie MS. Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med. 2004;10:580–583
   PubMed Web of Science ®Google Scholar
• Balentine JD. Pathology of experimental spinal cord trauma. The necrotic lesion as a function of vascular injury. Lab Invest. 1978;39:236–253
   PubMed Web of Science ®Google Scholar
• Wrathall JR, Teng YD, Choiniere D. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-daspartate receptors. Exp Neurol. 1996;137:119–126
   PubMed Web of Science ®Google Scholar
• Bao F, John SM, Chen Y, Mathison RD, Weaver LC. The tripeptide phenylalanine-(d)glutamate-(d) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord. Neuroscience. 2006;140:1011–1022
   PubMed Web of Science ®Google Scholar
• Liu NK, Zhang YP, Titsworth WL, et al. A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol. 2006;59:606–619
   PubMed Web of Science ®Google Scholar
• Acosta JA, Yang JC, Winchell RJ. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998;186:528–533
   PubMed Web of Science ®Google Scholar
• DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999;80:1411–1419
   PubMed Web of Science ®Google Scholar
• O' Connor PJ. Survival after spinal cord injury in Australia. Arch Phys Med Rehabil. 2005;86:37–47
   PubMed Web of Science ®Google Scholar
• Pickett GE, Campos-Benitez M, Keller JL, Duggal N. Epidemiology of traumatic spinal cord injury in Canada. Spine. 2006;31:799–805
   PubMed Web of Science ®Google Scholar
• Ozer MK, Parlakpinar H, Vardi N, Cigremis Y, Ucar M, Acet A. Myocardial ischemia/reperfusion-induced oxidative renal damage in rats: Protection by caffeic acid phenethyl ester (CAPE). Shock. 2005;24:97–100
   PubMed Web of Science ®Google Scholar
• Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care. 2001;7:221–226
   PubMedGoogle Scholar
• Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705
   PubMed Web of Science ®Google Scholar
• Engelhard K, Werner C, Eberspächer E, et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-d-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524–531
   PubMed Web of Science ®Google Scholar
• Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: Impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand. 2010;54:710–716
   PubMed Web of Science ®Google Scholar
• Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 2009;110:1077–1085
   PubMed Web of Science ®Google Scholar
• Zhang XY, Liu ZM, Wen SH, et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology. 2012;116:1035–1046
   PubMed Web of Science ®Google Scholar
• Yoshitomi O, Cho S, Hara T, et al. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs. Shock. 2012;38:92–97
   PubMed Web of Science ®Google Scholar
• Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153. doi: 10.1186/cc10283
   PubMed Web of Science ®Google Scholar
• Goyagi T, Tobe Y. Dexmedetomidine improves the histological and neurological outcomes 48 h after transient spinal ischemia in rats. Brain Res. 2014;1566:24–30
   PubMed Web of Science ®Google Scholar
• Bell MT, Puskas F, Bennett DT, et al. Dexmedetomidine, a α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. J Thorac Cardiovasc Surg. 2014;147:500–506
   PubMed Web of Science ®Google Scholar
• Gul S, Hanci V, Bahadir B, et al. The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats. J Clin Neurosci. 2010;17:490–494
   PubMed Web of Science ®Google Scholar
• Basso DM, Beattie MS, Brenham JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139:244–256
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247:3170–3175
   PubMed Web of Science ®Google Scholar
• Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–394
   PubMed Web of Science ®Google Scholar
• Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: Biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–590
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
   PubMed Web of Science ®Google Scholar
• Moron MS, Dipierre JW, Mannervik B. Levels of glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem Biophy Acta. 1979;582:67–68
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23–38
   PubMed Web of Science ®Google Scholar
• Toosi KK, Nagatomi J, Chancellor MB, Sacks MS. The effects of long-term spinal cord injury on mechanical properties of the rat urinary bladder. Ann Biomed Eng. 2008;36:1470–1480
   PubMed Web of Science ®Google Scholar
• Juan J, Herrera Ricky JL, Haywood-Watson II, Grill RJ. Acute and chronic deficits in the urinary bladder after spinal contusion injury in the adult rat. J Neurotrauma. 2010;27:423–431
   PubMed Web of Science ®Google Scholar
• Villela NR, do Nascimento Júnior P, de Carvalho LR, Teixeira A. Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs. Rev Bras Anestesiol. 2005;55:429–440
   PubMedGoogle Scholar
• Billings FT, Chen SW, Kim M, et al. Alpha2-adrenergic agonists protect against radio contrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:741–748
   Web of Science ®Google Scholar
• Chi OZ, Hunter C, Liu X, Weiss HR. The effects of dexmedetomidine on regional cerebral blood flow and oxygen consumption during severe hemorrhagic hypotension in rats. Anesth Analg. 2011;113:349–355
   PubMed Web of Science ®Google Scholar
• Juurlink BHJ, Paterson PG. Review of oxidative stress in brain and spinal cord injury: Suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med. 1998;21:309–334
   PubMedGoogle Scholar
• Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics. 2011;8:152–167
   PubMed Web of Science ®Google Scholar
• Bao F, Omana V, Brown A, Weaver LC. The systemic inflammatory response after spinal cord injury in the rat is decreased by a4b1 integrin blockade. J Neurotrauma. 2012;29:1626–1637
   PubMed Web of Science ®Google Scholar
• Liu J, Tang T, Yang H. Protective effect of deferoxamine on experimental spinal cord injury in rat. Injury. 2011;42:742–745
   PubMed Web of Science ®Google Scholar
• Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem. 1997;272:20313–20316
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med. 2006;10:389–406
   PubMed Web of Science ®Google Scholar
• Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience. 2002;115:839–849
   PubMed Web of Science ®Google Scholar
• Yune TY, Chang MJ, Kim SJ, et al. Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J Neurotrauma. 2003;20:207–219
   PubMed Web of Science ®Google Scholar
• Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140:105–112
   PubMed Web of Science ®Google Scholar
• Hanci V, Ero B, Bektaş S, et al. Effect of dexmedetomidine on testicular torsion/detorsion damage in rats. Urol Int. 2010;84:105–111
   PubMed Web of Science ®Google Scholar
• Kiliç K, Hanci V, Selek S, et al. The effects of dexmedetomidine on mesenteric arterial occlusion-associated gut ischemia and reperfusion-induced gut and kidney injury in rabbits. J Surg Res. 2012;178:223–232
   PubMed Web of Science ®Google Scholar
• Uysal HY, Cuzdan SS, Kayıran O, et al. Preventive effect of dexmedetomidine in ischemia-reperfusion injury. J Craniofac Surg. 2012;23:1287–1291
   PubMed Web of Science ®Google Scholar
• Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390:191–214
   PubMed Web of Science ®Google Scholar
• Erşahin M, Özdemir Z, Özsavcı D, et al. Melatonin treatment protects against spinal cord injury induced functional and biochemical changes in rat urinary bladder. J Pineal Res. 2012;52:340–348
   PubMed Web of Science ®Google Scholar
• Toklu HZ, Hakan T, Celik H, et al. Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats. J Spinal Cord Med. 2010;33:401–409
   PubMed Web of Science ®Google Scholar
• Matés JM, Segura JA, Alonso FJ, Márquez J. Intracellular redox status and oxidative stress: Implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol. 2008;82:273–299
   PubMed Web of Science ®Google Scholar
• Chang Y, Huang X, Liu Z, et al. Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro. J Surg Res. 2013;18:308–314
   Web of Science ®Google Scholar
• Kettle AJ, Winterbourn CC. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3–15
   PubMed Web of Science ®Google Scholar
• Can M, Gul S, Bektas S, et al. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury. Acta Anaesthesiol Scand. 2009;53:1068–1072
   PubMed Web of Science ®Google Scholar
• Lee SM, Yune TY, Kim SJ, et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma. 2003;20:1017–1027
   PubMed Web of Science ®Google Scholar
• Popovich PG, Stokes BT, Whitacre CC. Concept of autoimmunity following spinal cord injury: Possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res. 1996;45:349–363
   PubMed Web of Science ®Google Scholar
• Straub RH, Herrmann M, Berkmiller G, Frauenholz T, Lang B, Schölmerich Falk SW. Neuronal regulation of interleukin 6 secretion in murine spleen: Adrenergic and opioidergic control. J Neurochem. 1997;68:1633–1639
   PubMed Web of Science ®Google Scholar
• Maes M, Lin A, Kenis G, Egyed B, Bosmans E. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res. 2000;96:245–253
   PubMed Web of Science ®Google Scholar
• Szelényi J, Kiss JP, Vizi ES. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J Neuroimmunol. 2000;103:34–40
   PubMed Web of Science ®Google Scholar
• Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 2001;86:650–656
   PubMed Web of Science ®Google Scholar
• Dasari VR, Spomar DG, Cady C, Gujrati M, Rao JS, Dinh DH. Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res. 2007;32:2080–2093
   PubMed Web of Science ®Google Scholar
• Barut S, Unlü YA, Karaoğlan A, et al. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg Neurol. 2005;64:213–220
   PubMed Web of Science ®Google Scholar
• Knoblach SM, Huang X, Van Gelderen J, Calva-Cerqueira D, Faden AI. Selective caspase activation may contribute to neurological dysfunction after experimental spinal cord trauma. J Neurosci Res. 2005;80:369–380
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–7139
   PubMed Web of Science ®Google Scholar